Literature DB >> 8566261

The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.

A B Sener1, N C Seçkin, S Ozmen, O Gökmen, N Doğu, E Ekici.   

Abstract

OBJECTIVE: To evaluate and compare the effects of two different modalities of hormone replacement therapy (HRT) on the size of uterine fibroids.
DESIGN: Randomized clinical study.
SETTING: The Menopause Center of a public hospital. PATIENTS: Postmenopausal women with small asymptomatic uterine fibroids were selected.
INTERVENTIONS: One group was treated with 50 micrograms transdermal E2 plus 5 mg medroxyprogesterone acetate (MPA) continuously, whereas the second group was given 0.625 mg conjugated equine estrogen plus 2.5 mg MPA continuously. MAIN OUTCOME MEASURE: The size of the uterine fibroids was measured before and after the first year of HRT.
RESULTS: At the end of the first year on HRT, the size of the uterine fibroids was re-evaluated sonographically and no significant difference was found with the oral group, whereas there was a significant increase in the transdermal group.
CONCLUSION: Hormone replacement therapy with 50 micrograms transdermal E2 plus 5 mg MPA increases the size of the uterine fibroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566261     DOI: 10.1016/s0015-0282(16)58098-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.

Authors:  Xiaohua Gao; Linda Yu; Lysandra Castro; Alicia B Moore; Tonia Hermon; Carl Bortner; Maria Sifre; Darlene Dixon
Journal:  Toxicol Lett       Date:  2010-03-15       Impact factor: 4.372

2.  Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells.

Authors:  Shannon Whirledge; Darlene Dixon; John A Cidlowski
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

Review 3.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

4.  Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo.

Authors:  Vanida A Serna; Xin Wu; Wenan Qiang; Justin Thomas; Michael L Blumenfeld; Takeshi Kurita
Journal:  Endocr Relat Cancer       Date:  2018-04-26       Impact factor: 5.678

Review 5.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

6.  Effects of menopausal hormone therapy on uterine myoma in menopausal women.

Authors:  Ik Jin Chang; Gi Youn Hong; Young Lim Oh; Byoung Ryun Kim; Seong Nam Park; Hae-Hyeog Lee; Yong-Jin Na; Jeong Namkung
Journal:  J Menopausal Med       Date:  2013-12-27

Review 7.  The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.

Authors:  Elisa Moro; Eugenia Degli Esposti; Giulia Borghese; Federica Manzara; Margherita Zanello; Diego Raimondo; Giulia Gava; Alessandro Arena; Paolo Casadio; Maria Cristina Meriggiola; Renato Seracchioli
Journal:  Medicina (Kaunas)       Date:  2019-08-30       Impact factor: 2.430

Review 8.  Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review.

Authors:  Jacques Donnez
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.